Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
NVG-2089 by Nuvig Therapeutics for Chronic Inflammation: Likelihood of Approval
NVG-2089 is under clinical development by Nuvig Therapeutics and currently in Phase I for Chronic Inflammation. According to GlobalData, Phase...
Data Insights
NVG-2089 by Nuvig Therapeutics for Bullous Pemphigoid: Likelihood of Approval
NVG-2089 is under clinical development by Nuvig Therapeutics and currently in Phase I for Bullous Pemphigoid. According to GlobalData, Phase...